Testing effectiveness (Phase 2)Study completedNCT02533180
What this trial is testing
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
Who this might be right for
Liver TransplantLiver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100